Silvant Capital Management LLC Eli Lilly & CO Transaction History

Silvant Capital Management LLC

$2.23 Billion
Q3 2024

A detailed history of Silvant Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Silvant Capital Management LLC holds 93,465 shares of LLY stock, worth $74.4 Million. This represents 3.72% of its overall portfolio holdings.

Number of Shares

93,465

Previous 93,572 0.11%

Holding current value

$74.4 Million

Previous $84.7 Million 2.26%

% of portfolio

3.72%

Previous 3.81%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$772.14 - $960.02 $82,618 - $102,722	-107 Reduced 0.11%	93,465 $82.8 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $3.62 Million - $4.54 Million	-4,996 Reduced 5.07%	93,572 $84.7 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $4.15 Million - $5.55 Million	-7,006 Reduced 6.64%	98,568 $76.7 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $1.45 Million - $1.7 Million	-2,752 Reduced 2.54%	105,574 $61.5 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $8.22 Million - $11.3 Million	-18,918 Reduced 14.87%	108,326 $58.2 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $1.22 Million - $1.63 Million	3,465 Added 2.8%	127,244 $59.7 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $646,731 - $759,555	-2,082 Reduced 1.65%	123,779 $42.5 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $6.48 Million - $7.55 Million	-20,142 Reduced 13.8%	125,861 $0
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $36.9 Million - $42 Million	124,363 Added 574.69%	146,003 $47.2 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $8,919 - $10,472	32 Added 0.15%	21,640 $7.02 Million
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $59,845 - $74,373	-255 Reduced 1.17%	21,608 $6.19 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $213,157 - $264,529	-948 Reduced 4.16%	21,863 $6.04 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $930,276 - $1.14 Million	-4,198 Reduced 15.54%	22,811 $5.27 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $80,164 - $103,691	-444 Reduced 1.62%	27,009 $6.2 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $1.16 Million - $1.5 Million	7,049 Added 34.55%	27,453 $5.13 Million
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $2.45 Million - $3.25 Million	18,818 Added 1186.51%	20,404 $3.45 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $37,269 - $40,539	-349 Reduced 18.04%	1,586 $177,000
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $143,596 - $169,506	1,935 New	1,935 $150,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Account

Silvant Capital Management LLC Eli Lilly & CO Transaction History